Versicolor Treatment
Phase 3
- Conditions
- versicolor.Pityriasis versicolor
- Registration Number
- IRCT201107184808N4
- Lead Sponsor
- KURDISTAN University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion criteria are:Age above 14 years; KOH positive ; involvement of less than 10% of the body surface by the lesions.
Exclusion criteria are:Extensive involvement of the skin ; topical or systemic antifungal therapy; and use of steroid or antibiotic within the last month before starting the study;pregnancy or likelihood of pregnancy; lactation and the patients who are not cooperative
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PTRIASIS versicolor. Timepoint: After completion of the treatment course the patients will be requested to refer for follow up after 1 weeks, one month and two months of treatment or in case of recurrence of the lesions. Method of measurement: Skin smears are taken by a scalpel or a tape and will be examined by a pathologist for the presence of mycelium. The patients with positive smears will enter into the study.
- Secondary Outcome Measures
Name Time Method OCAL complications. Timepoint: after 2 weeks, one month and two months of treatment. Method of measurement: by a physician or patient self-report.